ALEX HAMIDI

Allopathic & Osteopathic Physicians|Emergency Medicine WILLIAMSBURG, VA NPI 1760945513

General Payments — all program years on this page

$77,404.41

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 43
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $49,182.85 across 24 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $49,174.6023
Travel and Lodging $8.251

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $49,182.8524

By program year

Program yearAmountRecords
2022 $9,034.996
2023 $19,186.5713
2024 $49,182.8524

Records — PY2024 (24)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1137569343 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 01/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569347 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 02/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569351 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 03/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569354 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 04/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569358 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 04/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569362 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 05/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569366 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 05/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569369 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 06/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569373 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 06/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569377 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569380 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569384 Takeda Pharmaceuticals U.S.A., Inc. $563.33 07/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569388 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 08/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569392 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 08/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569396 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 09/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569399 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 09/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569403 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 10/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569407 Takeda Pharmaceuticals U.S.A., Inc. $2,496.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569411 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 11/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569414 Takeda Pharmaceuticals U.S.A., Inc. $2,496.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569418 Takeda Pharmaceuticals U.S.A., Inc. $2,496.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569421 Takeda Pharmaceuticals U.S.A., Inc. $2,253.33 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137569425 Takeda Pharmaceuticals U.S.A., Inc. $8.25 12/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137569428 Takeda Pharmaceuticals U.S.A., Inc. $563.33 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.